通过纤维素网络不稳定性的选择性血栓溶解:一个未被识别的氨酸类似机制
Ning Yu1, Shule Zhang2, Rui Fang1
1Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.
Pharmacological research
|September 21, 2025
概括
八巴林是一种合成氨酸类似物,通过直接破坏纤维素凝块的稳定性,表现出强大的血栓抑制和抗凝剂作用. 这种新的机制与传统的血栓消毒剂相比,降低了出血风险.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 由于系统性等离子素激活,目前的血栓抑制药物存在显著的出血风险.
- 氨酸类似物是抗凝剂,但缺乏直接凝块溶解的能力.
研究的目的:
- 为了研究以前未被识别的催血酶机制的八巴,合成氨酸类似物.
- 为了评估与常规药物相比,octaparin在溶解血栓方面的有效性和安全性.
主要方法:
- 在实验室和体内研究中,使用小鼠血栓形成模型进行了实验.
- 分子对接,微尺度热泳和光谱分析纤维素-单体相互作用.
- 在人类系统中评估凝血参数和静血完整性.
主要成果:
- 八氨酸表现出强烈的抗凝血剂和血栓抑制活性,降低出血风险.
- 八巴林直接与纤维素单体结合,抑制聚合并破坏预先形成的血栓的稳定.
- 在肺栓塞和静脉血栓形成模型中有效溶解血块,而不会影响血静.
结论:
- 八巴林利用了一种针对性纤维素不稳定性的新机制来进行血栓溶解.
- 这种方法提供了一种比传统的血栓溶解疗法更安全的替代方案.
- 基于氨酸的分子设计可以产生有效和向的血栓溶解剂.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:29Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
01:16Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
01:30Venous Thrombosis I: Introduction
375
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
375
01:20Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K